First in-human radiation dosimetry of 68 Ga-NODAGA-RGDyK
First in-human radiation dosimetry of 68 Ga-NODAGA-RGDyK
About this item
Full title
First in-human radiation dosimetry of 68 Ga-NODAGA-RGDyK
Author / Creator
Publisher
Germany
Journal title
EJNMMI research, 2017-12, Vol.7 (1), p.43
Language
English
Formats
Publication information
Publisher
Germany
More information
Scope and Contents
Contents
Integrin-targeting radiopharmaceuticals have potential broad applications, spanning from cancer theranostics to cardiovascular diseases. We have previously reported preclinical dosimetry results of
Ga-NODAGA-RGDyK in mice. This study presents the first human dosimetry of
Ga-NODAGA-RGDyK in the five consecutive patients included in a clinical...
Alternative Titles
Full title
First in-human radiation dosimetry of 68 Ga-NODAGA-RGDyK
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_28523582
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_28523582
Other Identifiers
ISSN
2191-219X
E-ISSN
2191-219X
DOI
10.1186/s13550-017-0288-x
